Question

A 59-year-old with T2D, CKD G3a, albuminuria, and ASCVD already on ACE inhibitor and SGLT2 inhibitor asks about further CV risk reduction. A1c 7.4%. Which is reasonable to add?

Accepted Answer

GLP-1 receptor agonist with CV benefit

Answer

DPP-4 inhibitor for CV risk

Answer

Pioglitazone for CV prevention

Answer

Stop SGLT2 if A1c <7.5%

Answer

No change because A1c <8%

Practice question

A 59-year-old with T2D, CKD G3a, albuminuria, and ASCVD already on ACE inhibitor and SGLT2 inhibitor asks about further CV risk reduction. A1c 7.4%. Which is reasonable to add?